Subsequent to the development and global availability of BCR/ABL–targeted tyrosine kinase
inhibitors (TKIs), the prognosis of patients with chronic myeloid leukemia (CML), at least …

The development of the oral tyrosine kinase inhibitors (TKIs) to treat chronic myeloid
leukemia (CML) is one of the great triumphs of cancer research. Although the efficacy of TKIs …

Nonadherence to medications in cancer treatment protocols may be a particular concern
among adolescents and young adults (AYAs) with cancer and predictive of poor health …

Background With the global rise in chronic health conditions, health care is transforming,
and patient empowerment is being emphasized to improve treatment outcomes and reduce …

Aims Adherence to therapy is a key factor in successful treatment. The aim of this systematic
review is to assess the extent to which patients with better adherence to oral therapy have …

As the use of oral chemotherapy continues to rise, the issue of patient adherence is a
concerning aspect of cancer treatment. In this concurrent prospective and retrospective …

Objectives To obtain insight into patients' reasons for medication (non) adherence in chronic
myeloid leukaemia (CML) and needs and wishes regarding information and communication …

Health-related quality of life (HRQOL) assessment is important to facilitate decisions in the
current treatment landscape of chronic myeloid leukemia (CML). Therefore, the availability of …

Background Treatment-free remission (TFR) is becoming an essential goal for chronic
myeloid leukemia (CML) patients in clinical practice. Few studies have emphasized patient …

Background: Adherence to imatinib therapy has been significantly associated with disease
progression and direct medical costs in gastrointestinal stromal tumor (GIST) patients …